Quidel re-launches infectious mononucleosis test
This article was originally published in Clinica
Executive Summary
Quidel has re-launched its QuickVue+ lateral flow test for infectious mononucleosis in response to "strong customer demand". The San Diego, California firm stopped manufacturing the test in August 2007 "due to a heavy investment required to maintain the production line", it told Clinica. "At the time, we had a variety of other projects that provided us with a better long-term opportunity. After completion [of these], we turned our attention back to the mono product." Infectious mononucleosis, also known as mono and glandular fever, is caused by the Epstein-Barr virus and spread via saliva. Quidel's test provides results in five minutes and detects immunoglobulin M (IgM), an antibody that appears early in the course of infection.